Logo

EPAC

Enerpac Tool Group Corp.

EPAC

Enerpac Tool Group Corp. NYSE
$37.87 0.16% (+0.06)

Market Cap $2.05 B
52w High $49.45
52w Low $36.51
Dividend Yield 0.04%
P/E 22.28
Volume 157.09K
Outstanding Shares 54.05M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $167.515M $42.055M $28.081M 16.763% $0.52 $44.159M
Q3-2025 $158.661M $48.222M $22.044M 13.894% $0.41 $34.455M
Q2-2025 $145.528M $42.611M $20.901M 14.362% $0.38 $33.541M
Q1-2025 $145.196M $43.52M $21.723M 14.961% $0.4 $34.159M
Q4-2024 $158.714M $47.363M $24.416M 15.384% $0.45 $32.879M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $151.558M $827.867B $394.173B $433.694B
Q3-2025 $140.506M $828.104M $389.879M $438.225M
Q2-2025 $119.509M $776.627M $370.649M $405.978M
Q1-2025 $130.733M $775.351M $377.342M $398.009M
Q4-2024 $167.094M $777.328M $385.349M $391.979M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $28.08M $55.254M $-2.897M $-41.486M $11.052M $52.274M
Q3-2025 $22.044M $39.922M $-4.391M $-14.902M $20.997M $35.079M
Q2-2025 $20.901M $7.459M $-5.66M $-12.286M $-11.224M $1.799M
Q1-2025 $21.723M $8.649M $-33.053M $-12.783M $-36.361M $2.792M
Q4-2024 $23.409M $44.361M $-6.441M $-4.862M $34.732M $37.92M

Revenue by Products

Product Q1-2025Q2-2025Q3-2025Q4-2025
Industrial Tools Services Domain
Industrial Tools Services Domain
$140.00M $140.00M $150.00M $160.00M
Other Operating Segment
Other Operating Segment
$10.00M $0 $10.00M $10.00M

Five-Year Company Overview

Income Statement

Income Statement Enerpac’s income statement shows a steady, gradual build rather than explosive growth. Sales have trended upward over the past several years, but the more notable story is profit quality: gross margins have improved, and operating profits have risen faster than sales. That suggests better pricing power, a richer mix of higher‑value products, and tighter cost control. Net income and earnings per share have strengthened meaningfully from earlier years, though there was a softer patch a few years ago before the recent rebound. Overall, the business now looks more efficient and profitable than it did earlier in the period, but this progress still depends on healthy industrial demand, which can be cyclical.


Balance Sheet

Balance Sheet The balance sheet looks gradually stronger and cleaner over time. Total assets have been fairly steady, which hints at a capital‑light model, while equity has grown, signaling that profits are being retained and the company’s financial cushion is thicker than before. Debt has edged down from prior levels, which reduces financial risk and interest burden. Cash holdings are solid and have generally improved versus earlier years, providing flexibility for downturns and for strategic moves. In simple terms, Enerpac today appears less leveraged and more resilient than it was a few years ago.


Cash Flow

Cash Flow Cash generation has been consistently positive and has improved alongside earnings. Operating cash flow has grown over the period, and free cash flow has stayed positive each year, even during the weaker profit years. Investment in equipment and facilities has remained modest and stable, pointing to limited capital intensity and the ability to convert a good portion of earnings into cash. This pattern gives Enerpac room to fund product development, potential acquisitions, and shareholder returns, though future cash flow will still ebb and flow with industrial cycles and project timing.


Competitive Edge

Competitive Edge Enerpac occupies a specialized, high‑value corner of the industrial tools market, especially in high‑pressure hydraulics and precision lifting. Its brand is well known and trusted for safety and reliability in mission‑critical applications, which makes customers slower to switch to cheaper alternatives. A broad global distribution network and rental and service offerings deepen customer relationships and make it harder for smaller rivals to match coverage and support. A sizable patent portfolio and long track record on complex projects add to this moat. The main competitive risks are from large diversified tool makers trying to push into this niche, and from economic slowdowns that can delay big infrastructure and maintenance projects where Enerpac tools shine.


Innovation and R&D

Innovation and R&D Innovation is a core part of Enerpac’s identity. The company has developed advanced systems for synchronized heavy lifting, wireless control of gantries, and specialized digital tools for aerospace and power generation, all aimed at improving safety, precision, and labor efficiency. It has been an early mover in cordless and battery‑powered hydraulic solutions, aligning with the broader shift toward portable, power‑independent tools. The dedicated innovation lab and a large patent base support continued product refresh and customization for complex projects. Beyond core hydraulics, the Cortland Biomedical business opens a very different, higher‑growth medical niche, but also brings regulatory and execution uncertainty. Digital initiatives, including more e‑commerce and smarter, connected tools, could further strengthen the offering if execution matches ambition.


Summary

Enerpac today looks like a focused industrial tools company with improving fundamentals and a defensible niche. Profitability has strengthened more than sales, reflecting better mix and cost discipline, while the balance sheet has become less leveraged and more cash‑rich. Consistent free cash flow supports ongoing innovation and strategic flexibility. Competitively, Enerpac benefits from a strong brand, specialized know‑how, global reach, and an ecosystem of rentals, service, and training that is not easy to replicate. Its innovation engine—ranging from advanced lifting systems to cordless tools and biomedical textiles—offers multiple avenues for growth. The main uncertainties lie in its exposure to industrial and infrastructure cycles, the challenge of sustaining premium pricing in a competitive market, and the execution risk around acquisitions and diversification into new areas like biomedical. Overall, the financial and strategic picture points to a steady, quality‑oriented industrial business with meaningful but not risk‑free growth opportunities.